Unfortunately, they didn’t give details of any upcoming events....

Unfortunately, they didn’t give details of any upcoming events. I don't understand why the they can’t bring forward the update of the phase 1 trial a couple of months in line with the timing of this congress to allow them to present new data. Surely 120 week data is just as creditable as 130 week data.

This would have allowed the company to submit a poster presentation which would also raise awareness to the current phase of the trial. They may have received a special mention at this congress, this type of acknowledgement from a 3^rd party would certainly raise awareness of this treatment that internal PR can’t achieve.